Capital Analysts LLC’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Capital Analysts LLC's AXSM Position: Q3 2026 in Review
Capital Analysts LLC opened a new position in Axsome Therapeutics (AXSM) in Q3 2026: 2 shares worth $369. The stake represents ﹤0.01% of the portfolio and ranks #1627 among its holdings.
462 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Capital Analysts LLC held 2 shares of Axsome Therapeutics worth $369 as of Q3 2026.
- Axsome Therapeutics was a new Capital Analysts LLC position in Q3 2026.
- Axsome Therapeutics made up ﹤0.01% of Capital Analysts LLC's portfolio in Q3 2026, its #1627 holding.
- 462 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Capital Analysts LLC's 13F filing for Q3 2026, filed 13 Nov 2026.